Modulation Of Alendronate Release From A Calcium Phosphate Bone Cement: An In Vitro Osteoblast-Osteoclast Co-Culture Study

Luisa Stella Dolci, Silvia Panzavolta, Paola Torricelli, Beatrice Albertini, Laura Sicuro, Milena Fini, Adriana Bigi, Nadia Passerini

Research output: Contribution to journalArticle

Abstract

In this study, we loaded a biomimetic calcium phosphate bone cement (CPC) with relatively high amounts of a bisphosphonate through the use of Solid Lipid Microparticles (MPs) and investigated bone cells response to the composite cements. 10, 20 and 30% w/w of Alendronate (AL) were successfully introduced into microparticles of Cutina HR and Precirol, which were prepared by means of spray-congealing technique. Addition of AL-loaded MPs to the cement composition provoked a lengthening of the setting and of the hardening processes. However, setting times were still in a range useful for clinical applications, except for the cements at the highest Alendronate content. The composite cements displayed a sustained drug release over time. Cements with the best performances in terms of setting, hardening, mechanical properties and drug release were submitted to in vitro tests using a co-culture model of osteoblast and osteoclast. The results showed that the use of MPs to enrich the cement composition with Alendronate provides materials able to inhibit osteoclast viability and activity, while promoting osteoblast viability and earlier differentiation, indicating that the MPs-cements are good delivery systems for bisphosphonates.

Original languageEnglish
Pages (from-to)245-255
Number of pages11
JournalInternational Journal of Pharmaceutics
Volume554
DOIs
Publication statusPublished - Jan 10 2019

Fingerprint

Alendronate
Bone Cements
Osteoclasts
Coculture Techniques
Osteoblasts
Diphosphonates
Biomimetics
Lipids
Bone and Bones
In Vitro Techniques
calcium phosphate
Drug Liberation

Keywords

  • Calcium Phosphate Bone Cements
  • Osteoblast Osteoclast Cell Cultures
  • Sodium Alendronate
  • Solid Lipid Microparticles
  • Spray Congealing

Cite this

Modulation Of Alendronate Release From A Calcium Phosphate Bone Cement: An In Vitro Osteoblast-Osteoclast Co-Culture Study. / Dolci, Luisa Stella; Panzavolta, Silvia; Torricelli, Paola; Albertini, Beatrice; Sicuro, Laura; Fini, Milena; Bigi, Adriana; Passerini, Nadia.

In: International Journal of Pharmaceutics, Vol. 554, 10.01.2019, p. 245-255.

Research output: Contribution to journalArticle

Dolci, Luisa Stella ; Panzavolta, Silvia ; Torricelli, Paola ; Albertini, Beatrice ; Sicuro, Laura ; Fini, Milena ; Bigi, Adriana ; Passerini, Nadia. / Modulation Of Alendronate Release From A Calcium Phosphate Bone Cement: An In Vitro Osteoblast-Osteoclast Co-Culture Study. In: International Journal of Pharmaceutics. 2019 ; Vol. 554. pp. 245-255.
@article{4253287c8c244f5fa24395a5d54923d5,
title = "Modulation Of Alendronate Release From A Calcium Phosphate Bone Cement: An In Vitro Osteoblast-Osteoclast Co-Culture Study",
abstract = "In this study, we loaded a biomimetic calcium phosphate bone cement (CPC) with relatively high amounts of a bisphosphonate through the use of Solid Lipid Microparticles (MPs) and investigated bone cells response to the composite cements. 10, 20 and 30{\%} w/w of Alendronate (AL) were successfully introduced into microparticles of Cutina HR and Precirol, which were prepared by means of spray-congealing technique. Addition of AL-loaded MPs to the cement composition provoked a lengthening of the setting and of the hardening processes. However, setting times were still in a range useful for clinical applications, except for the cements at the highest Alendronate content. The composite cements displayed a sustained drug release over time. Cements with the best performances in terms of setting, hardening, mechanical properties and drug release were submitted to in vitro tests using a co-culture model of osteoblast and osteoclast. The results showed that the use of MPs to enrich the cement composition with Alendronate provides materials able to inhibit osteoclast viability and activity, while promoting osteoblast viability and earlier differentiation, indicating that the MPs-cements are good delivery systems for bisphosphonates.",
keywords = "Calcium Phosphate Bone Cements, Osteoblast Osteoclast Cell Cultures, Sodium Alendronate, Solid Lipid Microparticles, Spray Congealing",
author = "Dolci, {Luisa Stella} and Silvia Panzavolta and Paola Torricelli and Beatrice Albertini and Laura Sicuro and Milena Fini and Adriana Bigi and Nadia Passerini",
note = "Copyright {\circledC} 2018. Published by Elsevier B.V.",
year = "2019",
month = "1",
day = "10",
doi = "10.1016/j.ijpharm.2018.11.023",
language = "English",
volume = "554",
pages = "245--255",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",

}

TY - JOUR

T1 - Modulation Of Alendronate Release From A Calcium Phosphate Bone Cement: An In Vitro Osteoblast-Osteoclast Co-Culture Study

AU - Dolci, Luisa Stella

AU - Panzavolta, Silvia

AU - Torricelli, Paola

AU - Albertini, Beatrice

AU - Sicuro, Laura

AU - Fini, Milena

AU - Bigi, Adriana

AU - Passerini, Nadia

N1 - Copyright © 2018. Published by Elsevier B.V.

PY - 2019/1/10

Y1 - 2019/1/10

N2 - In this study, we loaded a biomimetic calcium phosphate bone cement (CPC) with relatively high amounts of a bisphosphonate through the use of Solid Lipid Microparticles (MPs) and investigated bone cells response to the composite cements. 10, 20 and 30% w/w of Alendronate (AL) were successfully introduced into microparticles of Cutina HR and Precirol, which were prepared by means of spray-congealing technique. Addition of AL-loaded MPs to the cement composition provoked a lengthening of the setting and of the hardening processes. However, setting times were still in a range useful for clinical applications, except for the cements at the highest Alendronate content. The composite cements displayed a sustained drug release over time. Cements with the best performances in terms of setting, hardening, mechanical properties and drug release were submitted to in vitro tests using a co-culture model of osteoblast and osteoclast. The results showed that the use of MPs to enrich the cement composition with Alendronate provides materials able to inhibit osteoclast viability and activity, while promoting osteoblast viability and earlier differentiation, indicating that the MPs-cements are good delivery systems for bisphosphonates.

AB - In this study, we loaded a biomimetic calcium phosphate bone cement (CPC) with relatively high amounts of a bisphosphonate through the use of Solid Lipid Microparticles (MPs) and investigated bone cells response to the composite cements. 10, 20 and 30% w/w of Alendronate (AL) were successfully introduced into microparticles of Cutina HR and Precirol, which were prepared by means of spray-congealing technique. Addition of AL-loaded MPs to the cement composition provoked a lengthening of the setting and of the hardening processes. However, setting times were still in a range useful for clinical applications, except for the cements at the highest Alendronate content. The composite cements displayed a sustained drug release over time. Cements with the best performances in terms of setting, hardening, mechanical properties and drug release were submitted to in vitro tests using a co-culture model of osteoblast and osteoclast. The results showed that the use of MPs to enrich the cement composition with Alendronate provides materials able to inhibit osteoclast viability and activity, while promoting osteoblast viability and earlier differentiation, indicating that the MPs-cements are good delivery systems for bisphosphonates.

KW - Calcium Phosphate Bone Cements

KW - Osteoblast Osteoclast Cell Cultures

KW - Sodium Alendronate

KW - Solid Lipid Microparticles

KW - Spray Congealing

U2 - 10.1016/j.ijpharm.2018.11.023

DO - 10.1016/j.ijpharm.2018.11.023

M3 - Article

VL - 554

SP - 245

EP - 255

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

ER -